Search Results

Olimel Portfolio

The Olimel portfolio consists of eight unique olive oil-based parenteral (intravenous) nutrition formulations designed to match the personalized protein and energy needs of patients.

Patricia B. Morrison

Patricia B. Morrison has served as a director of Baxter since 2019.

Amy A. Wendell

Amy A. Wendell has served as a director of Baxter since 2019.

Dawn Nixon

Dawn Nixon is vice president, Human Resources, Integrated Supply Chain, Quality and Learning Solutions. Nixon joined Baxter in 2011 and has held roles across Baxter’s human resources, Business Transformation Office and global learning solutions functions. Prior to joining Baxter, she held human resources management roles at Grainger Industrial Supply. Nixon received her bachelor’s degree in health and human development from Penn State University.

Piero Novello

Piero Novello is senior vice president and president, Growth & Emerging Markets.

Carl Wilt

Carl Wilt is vice president, Finance, Integrated Supply Chain & Quality. Wilt joined Baxter in 1987 and has held roles of increasing responsibility in the finance function, most recently as vice president, Global Business Units and Research & Development. He also served in vice president roles for our U.S. Hospital Products and Bioscience divisions.

David S. Wilkes, M.D.

David S. Wilkes, M.D. has served as a director of Baxter since 2021.